...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

GATC Biotech to be First European Service Provider for the PacBio RS

| Print |
Wednesday, 22 September 2010 13:30 (UTC + 2)

GATC_Biotech_logo

Pacific Biosciences single molecule, real-time sequencer RS expected to be installed in Konstanz in early 2011
 
Konstanz, Germany, September 22, 2010 / b3c newswire /GATC Biotech announced today that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRT™) sequencing technology. The new PacBio RS will be the fifth sequencing technology for GATC Biotech. The system is planned for installation in early 2011.
 
GATC Biotech plans to use the new platform for resolving structural variations, for example in human cancer genomes, and for the detection and confirmation of rare SNPs. In addition, the future application to enable direct sequencing of methylated bases will make the system attractive for regulatory studies, for example for the pharmaceutical or diagnostics industry.

 

“Pacific Biosciences has chosen GATC Biotech to be our first European service provider because the company is well experienced in applying major sequencing technologies in a broad spectrum of projects and in gearing up new sequencing technologies quickly for lab routines,” comments Terry Pizzie, Vice President, Europe for Pacific Biosciences.

 

“We are looking forward to offering our customers PacBio’s third-generation sequencing platform and are confident that we will be able to offer the SMRT technology to our customers within a short period of time after successful installation,” adds Thomas Pohl, Chief Technology Officer of GATC Biotech.

 

GATC Biotech is Europe’s leading sequencing service provider. The company more than doubled its staff within the past three years and has currently close to 120 employees.

 


Contact

GATC Biotech AG
Dr. Kerstin Stangier
Director Business Development
Jakob-Stadler-Platz 7
D-78467 Konstanz
Tel.: +49(0)7531-816065
Fax: +49(0)7531-816081
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
http://www.gatc-biotech.com